Merck Licenses CRISPR Gene-Editing Technology to Evotec

Merck Licenses CRISPR Gene-Editing Technology to Evotec

Merck, a leading science and technology company, announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. Evotec, an international biotechnology company headquartered in Hamburg, Germany,...